John‐John B. Schnog

4.3k citations

50 papers · 1.4k indexed · h-index 24

Genetics top 0.5%
Hematology top 1%
Physiology top 10%
Molecular Biology
Pediatrics, Perinatology and Child Health top 10%

Co-authors: Ashley J. Duits Dees P. M. Brandjes Frits A.J. Muskiet Bart J. Biemond Erfan Nur R.A. Rojer Hans‐Martin Otten Hugo Ten Cate
Topics: Hemoglobinopathies and Related Disorders (38 papers)Iron Metabolism and Disorders (20 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers)
Cited by: Genetics Hematology Physiology
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
Partner nations: Netherlands Curacao United States

In The Last Decade

John‐John B. Schnog

46 papers receiving 1.3k citations

Peers

Countries citing papers authored by John‐John B. Schnog

Since Specialization

Citations

This map shows the geographic impact of John‐John B. Schnog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John‐John B. Schnog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John‐John B. Schnog more than expected).

Fields of papers citing papers by John‐John B. Schnog

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John‐John B. Schnog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John‐John B. Schnog. The network helps show where John‐John B. Schnog may publish in the future.

Co-authorship network of co-authors of John‐John B. Schnog

This figure shows the co-authorship network connecting the top 25 collaborators of John‐John B. Schnog. A scholar is included among the top collaborators of John‐John B. Schnog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John‐John B. Schnog. John‐John B. Schnog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmaceutical company funding of cancer patient advocacy organizations in the Netherlands 2024 ·Journal of Cancer Policy ·(unknown),Ashley J. Duits,Michael Samson,John‐John B. Schnog	2
2	Design issues with lutetium-177 PSMA-617 registration studies that bias the outcome of the experimental arm reflect an increasing misalignment of contemporary oncology trials with true patient benefit 2024 ·SHILAP Revista de lepidopterología ·John‐John B. Schnog,Ashley J. Duits,Michael Samson	3
3	Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies 2023 ·The Lancet Regional Health - Americas ·(unknown),John‐John B. Schnog,Ingemar S. J. Merkies,Michael Samson	0
4	An urgent call to raise the bar in oncology 2021 ·British Journal of Cancer ·John‐John B. Schnog,Michael Samson,Rijk O. B. Gans,Ashley J. Duits	41
5	An unusual craving! 2015 ·PubMed ·Esther G. Gerrits,John‐John B. Schnog	2
6	Nucleosomes and neutrophil activation in sickle cell disease painful crisis 2013 ·Haematologica ·(unknown),Erfan Nur,Bart J. Biemond,G J van Mierlo,(unknown),Desiderius P.M. Brandjes,Hans‐Martin Otten,John‐John B. Schnog,Sacha Zeerleder,(unknown)	61
7	N-acetylcysteine reduces oxidative stress in sickle cell patients 2012 ·Annals of Hematology ·(unknown),Erfan Nur,Dees P. M. Brandjes,Tom Teerlink,Hans‐Martin Otten,Ronald P.J. Oude Elferink,Frits A.J. Muskiet,Ludo M. Evers,Hugo Ten Cate,Bart J. Biemond,Ashley J. Duits,John‐John B. Schnog	67
8	Increased efflux of oxidized glutathione (GSSG) causes glutathione depletion and potentially diminishes antioxidant defense in sickle erythrocytes 2011 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Erfan Nur,(unknown),Dirk R. de Waart,John‐John B. Schnog,Hans‐Martin Otten,Dees P. M. Brandjes,Bart J. Biemond,Ronald P.J. Oude Elferink	38
9	Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management 2011 ·American Journal of Hematology ·Erfan Nur,Bart J. Biemond,Hans‐Martin Otten,Dees P. M. Brandjes,John‐John B. Schnog,(unknown)	162
10	Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis 2011 ·Blood Cells Molecules and Diseases ·Erfan Nur,Eduard J. van Beers,(unknown),Ivan Cuccovillo,Hans-Martin Otten,John‐John B. Schnog,Joost C.M. Meijers,Alberto Mantovani,Dees P. M. Brandjes,Barbara Bottazzi,Bart J. Biemond	17
11	Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis 2010 ·American Journal of Hematology ·Erfan Nur,(unknown),Bart J. Biemond,Anton P. van Zanten,John‐John B. Schnog,Dees P. M. Brandjes,Hans‐Martin Otten,(unknown)	15
12	Elevated Circulating Stromal-Derived Factor-1 Levels in Sickle Cell Disease 2009 ·Acta Haematologica ·(unknown),Erfan Nur,Naomi I. Maria,Dees P. M. Brandjes,Bart J. Biemond,John‐John B. Schnog,Ashley J. Duits	8
13	Large and Medium-Sized Pulmonary Artery Obstruction Does Not Play a Role of Primary Importance in the Etiology of Sickle-Cell Disease-Associated Pulmonary Hypertension 2008 ·CHEST Journal ·Eduard J. van Beers,Berthe L.F. van Eck‐Smit,Melvin R. Mac Gillavry,Charlotte F.J. Van Tuijn,Joost W. J. van Esser,Dees P. M. Brandjes,M. C. Kappers‐Klunne,Ashley J. Duits,Bart J. Biemond,John‐John B. Schnog	10
14	Serum levels of angiogenic factors indicate a pro‐angiogenic state in adults with sickle cell disease 2006 ·British Journal of Haematology ·Ashley J. Duits,(unknown),John‐John B. Schnog,(unknown)	39
15	ADAMTS13 activity in sickle cell disease 2006 ·American Journal of Hematology ·John‐John B. Schnog,Johanna A. Kremer Hovinga,(unknown),Şakir Akın,Bernhard Lämmle,Dees P. M. Brandjes,Melvin R. Mac Gillavry,(unknown),Ashley J. Duits,(unknown)	48
16	Evidence for a metabolic shift of arginine metabolism in sickle cell disease 2004 ·Annals of Hematology ·John‐John B. Schnog,(unknown),Fey P.L. van der Dijs,Ashley J. Duits,Han Moshage,(unknown),Frits A.J. Muskiet	67
17	Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease 2004 ·Annals of Hematology ·(unknown),John‐John B. Schnog,Tom Teerlink,Fey P.L. van der Dijs,Ashley J. Duits,Frits A.J. Muskiet	56
18	Optimization of folic acid, vitamin B₁₂, and vitamin B₆ supplements in pediatric patients with sickle cell disease 2002 ·American Journal of Hematology ·Fey P.L. van der Dijs,M. Rebecca Fokkema,D.A. Janneke Dijck‐Brouwer,(unknown),(unknown),John‐John B. Schnog,Ashley J. Duits,(unknown),Frits A.J. Muskiet,(unknown),(unknown)	23
19	No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease 2002 ·American Journal of Hematology ·John‐John B. Schnog,Melvin R. Mac Gillavry,R.A. Rojer,Joost C.M. Meijers,Rob Fijnheer,Hugo Ten Cate,Dees P. M. Brandjes,Ashley J. Duits	8
20	New concepts in assessing sickle cell disease severity 1998 ·American Journal of Hematology ·John‐John B. Schnog,Leroy R. Lard,R.A. Rojer,Fey P.L. van der Dijs,Frits A.J. Muskiet,Ashley J. Duits	42

About John‐John B. Schnog

John‐John B. Schnog is a scholar working on Genetics, Hematology and Obstetrics and Gynecology, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (38 papers), Iron Metabolism and Disorders (20 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers). The work is most often cited by research in Genetics (1.0k citations), Hematology (757 citations) and Physiology (280 citations). John‐John B. Schnog has collaborated with scholars based in Netherlands, Curacao and United States. Frequent co-authors include Ashley J. Duits, Dees P. M. Brandjes, Frits A.J. Muskiet, Bart J. Biemond, Erfan Nur, R.A. Rojer, Hans‐Martin Otten, Hugo Ten Cate, Fey P.L. van der Dijs and Tom Teerlink. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact